Table 2 Clinical symptoms and laboratory findings of a cluster of 18 patients with SFTS

Clinical symptoms

 Fever

18(100)

4(100)

14(100)

 Nausea

2(11.1)

1(25.0)

1(7.1)

 Vomiting

2(11.1)

1(25.0)

1(7.1)

 Fatigue

10(55.6)

2(50.0)

8(57.1)

 Myalgia

2(11.1)

0(0)

2(14.3)

 Multiple organ failure

4(22.2)

4(100)

0(0)

 Tremors

1(5.6)

0(0)

1(7.1)

 Viral encephalitis

2(11.1)

2(50.0)

0(0)

 Proteinuria

12(66.7)

2(50.0)

10(71.4)

 Haematuria

6(33.3)

1(25.0)

5(35.7)

Laboratory findings

 Platelet count (Peak), (×10⁹/L)

48–385

55–385

48–223

 Platelet count (Nadir), (×10⁹/L)

17–173

17–106

47–173

 White blood cell count (Peak), (×10⁹/L)

1.7–47.41

1.77–47.41

1.7–12.99

 White blood cell count (Nadir), (×10⁹/L)

0.83–5.58

0.83–3.8

1.21–5.58

 Alanine aminotransaminase (Peak), (u/ml)

10–595

10–595

28–114

 Alanine aminotransaminase (Nadir), (u/ml)

10–595

10–595

13–92

 Creatine kinase (Peak), (u/L)

29–21980

82–21980

29–4794

 Creatine kinase (Nadir), (u/L)

20–3374

81–3374

20–383

 Lactate dehydrogenase (Peak), (u/L)

197–26990

460–26990

197–814

 Lactate dehydrogenase (Nadir), (u/L)

181–3364

191–3364

181–463

 Creatinine (Peak), (mmol/L)

50.4–448

68.2–448

50.4–102.6

 Creatinine (Nadir), (mmol/L)

42.7–220

68.2–220

42.7–91.9

 Prothrombin time (Peak), (s)

10.1–38.6

11.4–22.8

10.1–38.6

 Prothrombin time (Nadir), (s)

10.1–38.6

11.3–12

10.1–38.6

 Activated partial thromboplastin time (Peak), (s)

15.4–146

15.4–146

17.8–63.3

 Activated partial thromboplastin time (Nadir), (s)

15.4–60.2

15.4–60.2

17.8–51.6

 Fibrinogen (Peak), (g/L)

1.77–3.63

2.32–3.44

1.77–3.63

 Fibrinogen (Nadir), (g/L)

1.15–3.63

1.15–3.44

1.77–3.63